Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Progress in Neuro-Psychopharmacology and Biological Psychiatry | Jan 26, 2018
Reiche S, et al. - Researchers investigated serotonergic hallucinogens for the treatment of anxiety associated with life-threatening diseases. Because of their anxiolytic and antidepressant properties, serotonergic hallucinogens proved beneficial in patients with life threatening diseases associated with symptoms of depression and anxiety. In a clinical setting, substances exhibited a reasonable safety profile.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
